Ardelyx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Ardelyx (NASDAQ:ARDX), a biopharmaceutical company focused on developing first-in-class medicines, has announced its participation in four major investor conferences in September 2025:

• Citi Biopharma Back to School Summit in Boston (Sept 3)
• Cantor Global Healthcare Conference in New York (Sept 4)
• Morgan Stanley 23rd Annual Global Healthcare Conference in New York (Sept 8)
• H.C. Wainwright 27th Annual Global Investment Conference in New York (Sept 9)

Live webcasts of the fireside chats and presentations will be available on Ardelyx's investor relations website, with replays accessible for 30 days after each event.

WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced its participation in the following upcoming investor conferences:

Citi Biopharma Back to School Summit
Location: Boston, MA
Fireside Chat: Wednesday, September 3 at 1:00 p.m. ET
1x1 Meetings: Wednesday, September 3

Cantor Global Healthcare Conference
Location: New York, NY
Fireside Chat: Thursday, September 4 at 8:35 a.m. ET
1x1 Meetings: Thursday, September 4

Morgan Stanley 23rd Annual Global Healthcare Conference
Location: New York, NY
Fireside Chat: Monday, September 8 at 7:00 a.m. ET
1x1 Meetings: Monday, September 8

H.C. Wainwright 27th Annual Global Investment Conference
Location: New York, NY
Presentation: Tuesday, September 9 at 11:30 a.m. ET
1x1 Meetings: Tuesday, September 9

To access the live webcast of the Fireside Chats, please visit the Events and Presentations page within the Ardelyx website at ir.ardelyx.com. A replay of the sessions will be available on the Ardelyx website for 30 days following the event.

About Ardelyx
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA^® (tenapanor) and XPHOZAH^® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL^® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

FAQ

When is Ardelyx (ARDX) presenting at the Morgan Stanley Healthcare Conference 2025?

Ardelyx will hold a fireside chat at the Morgan Stanley Conference on Monday, September 8, 2025, at 7:00 a.m. ET in New York.

How can investors access Ardelyx's (ARDX) conference presentations in September 2025?

Investors can access the live webcasts of the fireside chats through the Events and Presentations page on Ardelyx's website at ir.ardelyx.com. Replays will be available for 30 days after each event.

Which investor conferences is Ardelyx (ARDX) attending in September 2025?

Ardelyx is attending four conferences: Citi Biopharma Back to School Summit (Sept 3), Cantor Global Healthcare Conference (Sept 4), Morgan Stanley Global Healthcare Conference (Sept 8), and H.C. Wainwright Global Investment Conference (Sept 9).

Where will the Ardelyx (ARDX) investor conferences be held in September 2025?

The Citi conference will be held in Boston, while the Cantor, Morgan Stanley, and H.C. Wainwright conferences will all take place in New York.